The rise in plasma renin activity (PRA) that accompanies thiazide diuretic therapy of hypertension may interfere with therapeutic effectiveness and contribute to hypokalemia. In an attempt to provide a basis for the previously empiric use of antihypertensive drugs, 20 hypertensive subjects were given a diuretic alone for three weeks and a diuretic plus methyldopa, which lowers PRA, for three weeks. The thiazide-induced rise in PRA was blunted by the methyldopa, while blood pressure fell even more and renal function was well maintained. The combination of a renin-lowering drug and a diuretic is rational and effective therapy for hypertension.
|Original language||English (US)|
|Number of pages||4|
|Journal||Archives of Internal Medicine|
|State||Published - May 1975|
ASJC Scopus subject areas
- Internal Medicine